 Hepatitis
B Top News Articles
 |
| |
|
|
| Executive
Summary Now Available from Hepatitis B and C National
Expert Policy Forum |
Entecavir
(Baraclude) Improves Liver Function in Chronic
Hepatitis B Patients with Decompensated Cirrhosis
2-05-2010
|
Perinatal
HBV Transmission May Occur Despite Newborn
Vaccination and Immune Globulin
2-05-2010
|
Long-term
Entecavir (Baraclude)
Produces Sustained Viral Suppression with Little Resistance
in HBeAg Positive Chronic Hepatitis B Patients
1-26-2010
|
Clinical
Course of Chronic Hepatitis B
in Children
1-22-2010
|
Chronic
Hepatitis B Patients with Liver
Cirrhosis Are at Risk for Lactic Acidosis after
Starting Entecavir (Baraclude)
1-22-2010
|
Chronic
Hepatitis B Patients with Liver Cirrhosis Are at Risk
for Lactic Acidosis after Starting Entecavir
(Baraclude)
1-19-2010
|
Tenofovir
(Viread) Produces Long-term Response in Chronic
Hepatitis B Patients with Prior Treatment Failure
1-15-2010
|
New
Institute of Medicine Report Outlines National Strategy
for Prevention and Control of
Hepatitis B and C
1-12-2010
|
Factors
that Predict Response to Pegylated
Interferon in HBeAg Positive Chronic Hepatitis
B Patients
1-08-2010
|
Patients
with HBV/HCV Coinfection May Experience HBV
Relapse after Sustained HCV Suppression
12-15-2009
|
Fewer
Viral Hepatitis Patients with End-stage Liver Disease
Are Awaiting Liver Transplants,
Likely Due to Effective Hepatitis B Treatment
12-11-2009
|
New
Study to Test Interleukin 7
in Combination with Antiviral Therapy and Vaccine for
Chronic Hepatitis B
12-11-2009
|
Tenofovir
(Viread) Produces Good HBV Suppression in Chronic
Hepatitis B Patients with Resistance to Adefovir
(Hepsera)
11-24-2009
|
Long-term
Data Show Telbivudine (Tyzeka)
Suppresses HBV Viral Load and Leads to HBeAg Clearance
in Chronic Hepatitis B Patients
11-24-2009
|
Review
Finds Pegylated Interferon
Is More Effective than Lamivudine for Chronic Hepatitis
B, but Study Shows Little Activity against HBV Genotype
D
11-17-2009
|
Early
HBsAg Decline Predicts Sustained Response to Pegylated
Interferon; Extended Treatment Can Improve
Outcomes
11-17-2009
|
Entecavir
(Baraclude) and Tenofovir (Viread) Rescue Therapy
for Chronic Hepatitis B Patients with Advanced Fibrosis
and Prior Treatment Failure
11-13-2009
|
High
HBV Viral Load and Being HBeAg Positive Are Associated
with Decreased Life Expectancy
for People with Hepatitis B
11-3-2009
|
Tenofovir
(Viread) Regimens Are Effective and Well-tolerated
in Chronic Hepatitis B Patients with Decompensated Liver
Disease
11-10-2009
|
Long-term
Studies Show Tenofovir (Viread)
Safety and Efficacy Is Sustained at 3 Years in HBeAg Positive
and Negative Hepatitis B Patients
11-3-2009
|
Entecavir
(Baraclude) Demonstrates Greater Antiviral
Activity than Adefovir (Hepsera)
in Hepatitis B Patients with Decompensated Liver Disease
11-3-2009
|
AASLD
Liver Meeting Starts
Today in Boston
10-30-2009
|
Hepatitis
B Virus Genotypes E, F, G, and H Appear Responsive to
Treatment with Interferon Alpha
10-13-2009
|
Most
Patients with Low Baseline HBV Viral Load Can Safely Discontinue
Lamivudine (Epivir-HBV)
after Achieving Virological Suppression
10-09-2009
|
Widespread
Hepatitis B Vaccination
Has Dramatically Reduced Rate of Liver Cancer among Children
and Young Adults in Taiwan
9-29-2009
|
AASLD
Issues Updated Practice Guidelines for Management of Chronic
Hepatitis B
9-22-2009
|
Sustained
Response in HBeAg Negative Chronic Hepatitis B Patients
3 Years After Treatment with
Pegasys
8-18-2009
|
FDA
Changes Regulations for Expanded
Access to Investigational Drugs
8-14-2009 |
Predictors
of Good Response to Telbivudine
(Tyzeka) for Chronic Hepatitis B
8-4-2009
|
Vertex
Aims to Receive $250 Million in Milestone Payments for
Anti-HCV Drug Telaprevir
after Approval in Europe
7-14-2009
|
CDC
Researchers Release Latest Hepatitis
A, B, and C Statistics
6-23-2009
|
Many
People with Chronic Hepatitis
B and C Do Not Receive Appropriate Treatment
6-16-2009
|
High
HBV DNA Level Is the Strongest Predictor of
Elevated ALT
6-9-2009
|
Should
Entecavir (Baraclude)
and Tenofovir (Viread)
Be First-line Treatment for Chronic Hepatitis B?
6-5-2009 |
Slides
and Posters on Entecavir (Baraclude)
and Hepatitis B Liver Disease Progression Presented at
DDW 2009
6-5-2009 |
Factors
Associated with Development of Hepatocellular
Carcinoma in Chronic Hepatitis B Patients
6-2-2009
|
Does
HBV Viral Load Level
Predict Development of Liver Fibrosis?
5-29-2009
|
Study
Suggests Genetic Factors
May Help Explain High Rates of Hepatitis B among Asians
5/22/09 |
Researchers
Present Data on Investigational Cyclophilin Inhibitors
Debio 025 and SCY-635
5/15/09
|
Telbivudine
(Tyzeka) Continues to Produce Good Results
for Chronic Hepatitis B Patients after 3 Years
5/08/09
|
Tenofovir
(Viread) Is Similarly Effective in Chronic
Hepatitis B Patients Regardless of Liver Cirrhosis Status
5/08/09
|
Addition
of Emtricitabine (Emtriva)
Does Not Improve Response to Tenofovir
(Viread) for Chronic Hepatitis B
5/05/09
|
Half
of HBeAg Negative Chronic Hepatitis B Patients Maintain
Response up to 5 Years after Stopping Long-term Adefovir
(Hepsera)
5/05/09
|
Chronic
Hepatitis B Patients Who Had Incomplete Response or Relapse
on Adefovir (Hepsera)
Respond Well to Entecavir (Baraclude)
5/01/09
|
Safety
and Efficacy of 96 Weeks of Tenofovir
(Viread) in Chronic Hepatitis B Patients Previously
Treated with Lamivudine (Epivir-HBV)
4/28/09
|
Pharmasset
Halts Clinical Trials of Clevudine
for Chronic Hepatitis B Due to Safety Concerns, Will Focus
on Hepatitis C Pipeline
4/24/09
|
Studies
of Hepatitis B and
C Virus Interaction Produce Conflicting Results
4/17/09
|
Some
Individuals Harbor HBV with Adefovir
(Hepsera) and Tenofovir (Viread) Resistance Mutations
before They Ever Receive Treatment
4/17/09
|
Pegylated
Interferon Monotherapy for Treatment of Chronic
Hepatitis B
4/07/09
|
ImQuest
Identifies First Non-nucleoside
Inhibitors of Hepatitis B Virus
4/07/09
|
Meta-analysis
Shows Interferon Reduces Progression to Cirrhosis
and Liver Cancer in People with Chronic Hepatitis
B
4/03/09
|
Chronic
Hepatitis B Patients May Need to Begin Liver
Cancer Screening at a Younger Age than Currently
Recommended
3/27/09
|
Two
Year Tenofovir Disoproxil Fumarate
(TDF) Treatment and Adefovir Dipivoxil (ADV)
Switch Data in HBeAg-Positive Patients With Chronic Hepatitis
B (Study 103)
3/27/09
|
Variables
Impacting Treatment and Prognosis in Young Patients (under
Age 40) who Develop Hepatitis
B Virus-Associated Hepatocellular Carcinoma;
Implications for Management of an Unscreened Population
3/27/09
|
Two
Year Tenofovir Disoproxil Fumarate
(TDF) Treatment and Adefovir Dipivoxil (ADV)
Switch Data in HBeAg-Negative Patients with Chronic Hepatitis
B (Study 102)
3/27/09
|
Tenofovir
Disoproxil Fumarate (TDF) versus Adefovir Dipivoxil (ADV)
in Asians with HBeAg-Positive and HBeAg-Negative Chronic
Hepatitis B Participating in Studies 102 and 103
3/27/09 |
Many
Asian-American Primary Care Providers Do Not Screen their
Asian-American Patients Who Are at Risk for Chronic
Hepatitis B
3/24/09
|
Tenofovir
(Viread) during Pregnancy: Findings from the
Antiretroviral Pregnancy Registry
3/24/09
|
Frequent
Liver Function Tests Can Detect Transient ALT
Increases in Chronic Hepatitis B Patients
3/20/09 |
Entecavir
(Baraclude) Produces Greater Early HBV DNA
Suppression than Adefovir (Hepsera) in Chronic Hepatitis
B Patients
3/17/09 |
Telbivudine
(Tyzeka) May Be Effective for Chronic Hepatitis
B Treatment after Failure of Adefovir (Hepsera)
3/10/09 |
GLOBE
Trial 2-Year Data Shows Telbivudine
(Tyzeka) Is More Effective than Lamivudine
(Epivir-HBV) for Chronic Hepatitis B
2/27/2009 |
HBV
Relapse after 48 Weeks of Entecavir
(Baraclude) Suggests Need for Continuous Therapy
2/24/2009 |
Hepatitis
Delta Increases the Risk of Liver Cirrhosis and Hepatocellular
Carcinoma in People with Hepatitis
B
2/24/2009 |
Does
Telbivudine (Tyzeka)
Have Activity Against HIV?
2/17/2009 |
Despite
Infrequent "Blips," Tenofovir
(Viread) Provides Good Hepatitis B Virus Suppression
HIV-HBV Coinfected Individuals
2/17/2009 |
Japanese
Study Finds Entecavir (Baraclude)
Is Effective and Well-tolerated in Treatment-naive Chronic
Hepatitis B Patients
2/10/2009 |
Monday
Is Deadline to Apply for Association of Asian Pacific
Community Health Organizations Hepatitis
B Policy Fellowship
2/06/2009 |
European
Association for the Study of the Liver (EASL) Publishes
First Guidelines for Management
of Chronic Hepatitis B
2/03/2009 |
Japanese
Study Finds Entecavir (Baraclude)
Is Effective and Well-tolerated in Treatment-naive Chronic
Hepatitis B Patients
2/03/2009 |
Insulin
Resistance in Chronic Hepatitis B Patients
Is Associated with Other Metabolic Abnormalities, Not
HBV Infection Itself
1/30/2009 |
CDC
Finds Failure to Follow Proper
Infection-control Procedures Put More than
60,000 People at Risk for Hepatitis
B and C over the Past Decade
1/30/2009 |
Adefovir
(Hepsera) Prevents Post-transplant HBV Recurrence
as well as HBIG
1/27/2009 |
Final
Statement from Consensus
Development Conference on Management
of Hepatitis B
1/13/2009 |
Liver
Cirrhosis Is Common in HBeAg Negative Chronic
Hepatitis B Patients, especially Those with High ALT and
HBV DNA Levels
1/23/2009
|
Organizers
Announce 13th International Symposium
on Viral Hepatitis and Liver Disease, March
20-24 in Washington, DC
1/23/2009
|
Higher
Dose of Adefovir (Hepsera)
Are Not Effective for Chronic Hepatitis B Patients with
Lamivudine (Epivir) Resistance
1/09/2009 |
Significance
of HBV DNA Levels
in People with HBeAg Negative Chronic Hepatitis B
1/05/2009 |
|
Perinatal
HBV Transmission and Management of Pregnant Women with
Hepatitis B
12/12/2008 |
Do
HBeAg Negative Chronic Hepatitis B Patients with Low HBV
Viral Load Require Liver Biopsy?
12/08/2008 |
 Tenofovir
(Viread) versus Adefovir (Hepsera) for the Treatment of
Chronic Hepatitis B
12/05/2008 |
 Baseline
CD4 Cell Count Predicts HBV DNA Decline in HIV Negative
and HIV Positive Patients Treated with Adefovir (Hepsera)
12/05/2008 |
